1020 related articles for article (PubMed ID: 18277882)
21. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
22. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
[TBL] [Abstract][Full Text] [Related]
23. Glypican-3 expression in primary and recurrent ovarian carcinomas.
Stadlmann S; Gueth U; Baumhoer D; Moch H; Terracciano L; Singer G
Int J Gynecol Pathol; 2007 Jul; 26(3):341-4. PubMed ID: 17581422
[TBL] [Abstract][Full Text] [Related]
24. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
[TBL] [Abstract][Full Text] [Related]
25. Expression of glypican 3 in ovarian and extragonadal germ cell tumors.
Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ
Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091
[TBL] [Abstract][Full Text] [Related]
26. Glypican-3 is expressed in chromophobe renal cell carcinomas.
Okoń K
Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
[TBL] [Abstract][Full Text] [Related]
27. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
Rougemont AL; Tille JC
Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
[TBL] [Abstract][Full Text] [Related]
28. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
29. Oncofetal protein glypican-3 in testicular germ-cell tumor.
Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
[TBL] [Abstract][Full Text] [Related]
30. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Anatelli F; Chuang ST; Yang XJ; Wang HL
Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
32. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
33. Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.
Suzuki S; Yoshikawa T; Hirosawa T; Shibata K; Kikkawa F; Akatsuka Y; Nakatsura T
Cancer Sci; 2011 Sep; 102(9):1622-9. PubMed ID: 21668581
[TBL] [Abstract][Full Text] [Related]
34. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
Miller JS; Lee TK; Epstein JI; Ulbright TM
Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
[TBL] [Abstract][Full Text] [Related]
35. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.
Baumhoer D; Tornillo L; Stadlmann S; Roncalli M; Diamantis EK; Terracciano LM
Am J Clin Pathol; 2008 Jun; 129(6):899-906. PubMed ID: 18480006
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
37. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features.
Ulbright TM; Roth LM; Brodhecker CA
Am J Surg Pathol; 1986 Mar; 10(3):151-64. PubMed ID: 2420222
[TBL] [Abstract][Full Text] [Related]
38. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
39. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
[TBL] [Abstract][Full Text] [Related]
40. Krukenberg tumor with yolk sac tumor differentiation.
Zamecnik M; Voltr L; Stuk J; Chlumska A
Int J Gynecol Pathol; 2008 Apr; 27(2):223-8. PubMed ID: 18317220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
